Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

BIOXCEL THERAPEUTICS INC (BTAI)

37 + Investors. Track Smart Money conviction in BTAI. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -5
Streak
1Q ▼
Buyers last Q
46%

Smart Money Signals — BTAI

Based on 37 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their BTAI positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 88% of 3.0Y peak

88% of all-time peak
37 funds currently hold this stock — 88% of the 3.0-year high of 42 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +23% more funds vs a year ago

fund count last 6Q
+7 new funds entered over the past year (+23% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟠

More sellers than buyers — 46% buying

17 buying20 selling
Last quarter: 20 funds reduced or exited vs 17 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~7 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 9 → 12 → 11 → 7. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔄

Mostly new holders — 43% entered in last year

■ 3% conviction (2yr+) ■ 54% medium ■ 43% new
Only 1 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares +54%, value +28%

Value
+27%
Shares
+53%
Last quarter: funds added +54% more shares while total portfolio value only changed +28%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~7 new funds/quarter

29 → 9 → 12 → 11 → 7 new funds/Q
New funds entering each quarter: 9 → 12 → 11 → 7. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🌱

Early stage — 95% of holders entered in last year

■ 5% veterans ■ 0% 1-2yr ■ 95% new
Of 37 current holders: 35 (95%) entered in the past year, only 2 (5%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
🏆

Elite ownership — 47% AUM from top-100 funds

47% from top-100 AUM funds
11 of 37 holders are among the 100 largest funds by AUM, controlling 47% of total institutional value in BTAI. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.1
out of 10
Moderate Exit Risk
Exit risk score 4.1/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — BTAI

In 2026 Q1, 17 hedge funds were net buyers of BTAI (7 opened a new position, 10 added to an existing one), while 20 reduced or exited (8 trimmed, 12 sold completely) — a 46% buyer ratio, indicating roughly balanced activity. 47% of total institutional value in BTAI is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -5 funds (more exits than new entries). Total institutional holders: 37.

Hedge Fund Ownership: BTAI

How many hedge funds hold BTAI — quarterly history vs. share price
Quarterly hedge fund ownership of BTAI vs. share price

Market Analysis: BTAI

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: BTAI

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy BIOXCEL THERAPEUTICS INC (BTAI) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much BTAI has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 51d ago
BTAI
-19.3%
XLV
+0.4%

BTAI outperformed XLV by -19.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 6d ago
BTAI
-9.9%
XLV
+1.4%

Since the filing became public, BTAI outperformed XLV by -11.3% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: BTAI
37 + Investors

Track Smart Money conviction in BTAI. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 37 42 -11.9%
13F Shares 5M 4M 53.75%
Total Value $7M $6M 27.58%
New Positions 7 11 -4
Increased Positions 10 12 -2
Closed Positions 12 5 +7
Reduced Positions 8 7 +1
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: BTAI

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

37 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in BTAI. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of BTAI — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Oaktree Fund Advisors, LLC 0.10% 42,913 $58K
2 ARMISTICE CAPITAL, LLC 0.05% 1,910,076 $2.6M
3 OAKTREE CAPITAL MANAGEMENT LP 0.01% 241,188 $323K
4 EverSource Wealth Advisors, LLC 0.00% 1,772 $74K
5 Portfolio Strategies, Inc. 0.00% 12,178 $16K
6 MILLENNIUM MANAGEMENT LLC 0.00% 1,936,760 $2.6M
7 &PARTNERS 0.00% 80,864 $108K
8 Silver Grove Financial Group, Inc. 0.00% 334 —
9 DIVERSIFY WEALTH MANAGEMENT, LLC 0.00% 15,000 $16K
10 Man Group plc 0.00% 96,473 $129K
11 Beacon Pointe Advisors, LLC 0.00% 18,877 $25K
12 JONES FINANCIAL COMPANIES LLLP 0.00% 131,789 $166K
13 Tower Research Capital LLC (TRC) 0.00% 1,718 $2K
14 HighTower Advisors, LLC 0.00% 41,000 $55K
15 Annis Gardner Whiting Capital Advisors, LLC 0.00% 156 —
16 OSAIC HOLDINGS, INC. 0.00% 16,214 $22K
17 VANGUARD FIDUCIARY TRUST CO 0.00% 84,921 $114K
18 Washington Trust Advisors, Inc. 0.00% 160 —
19 Parkside Financial Bank & Trust 0.00% 112 —
20 UBS Group AG 0.00% 52,788 $71K
21 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 207,339 $278K
22 FMR LLC 0.00% 90,300 $121K
23 BlackRock, Inc. 0.00% 84,282 $113K
24 WELLS FARGO & COMPANY/MN 0.00% 4,319 $6K
25 MORGAN STANLEY 0.00% 10,588 $14K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — BIOXCEL THERAPEUTICS INC (BTAI)

What does the Smart Money Trend signal show for BTAI?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their BTAI positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for BTAI?

More sellers than buyers — 46% buying: Last quarter: 20 funds reduced or exited vs 17 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for BTAI holders?

Elite ownership — 47% AUM from top-100 funds: 11 of 37 holders are among the 100 largest funds by AUM, controlling 47% of total institutional value in BTAI. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held BTAI?

Mostly new holders — 43% entered in last year: Only 1 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy BIOXCEL THERAPEUTICS INC (BTAI) following the 2026 Q1 hedge fund 13F filings?

As of today, BTAI has moved -9.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +1.4% for the XLV sector ETF — an outperformance of -11.3%. Since the quarter end (March 31, 2026), BTAI has gained -19.3% vs +0.4% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →